KalVista Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
KALV on Nasdaq
Industry
Pharmaceutical Preparations
Location
55 Cambridge Parkway, Suite 901 E, Cambridge, MA

Insiders trading volume in the past year

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners III, L.P. 10%+ Owner $80.9M +$26.1M +47.6% Feb 20, 2024
Benjamin L. Palleiko CHIEF EXECUTIVE OFFICER, Director $5.48M -$1.67M -23.4% Nov 17, 2024
Thomas Andrew Crockett CEO, Director $4.65M -$1.75M -27.3% Feb 17, 2024
Paul K. Audhya Chief Medical Officer $2.01M -$554K -21.6% Nov 17, 2024
Christopher Yea Chief Development Officer $1.51M -$1.08M -41.7% Nov 17, 2024
Edward P. Feener Chief Scientific Officer $1.2M -$1.44M -54.5% May 17, 2024
Michael David Smith Senior VP, Development $127K May 17, 2022
Brian JG Pereira Director Oct 3, 2024
Nancy Stuart Director Oct 3, 2024
Daniel B. Soland Director Sep 30, 2021
Andreas Maetzel Senior Vice President, Medical May 26, 2021
William Fairey Director Oct 3, 2024
Edward W. Unkart Director Oct 3, 2024
Brian Piekos Chief Financial Officer Sep 9, 2024
Albert Cha Director Sep 26, 2023
Martin Edwards Director Sep 30, 2021
Patrick Treanor Director Oct 3, 2024

Recent Insider Transactions by Companies or Individuals for KalVista Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.